{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:31:22Z","timestamp":1792211482631,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,31]]},"DOI":"10.7759\/cureus.12395","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T12:31:15Z","timestamp":1609417875000},"source":"Crossref","is-referenced-by-count":4,"title":["Pembrolizumab-Induced Sarcoid-Like Reaction in a Patient With Lung Cancer"],"prefix":"10.7759","author":[{"given":"Hira","family":"Yousuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheid","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khizer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy. https.\/\/www.nice.org.uk\/guidance\/ta428."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0073","article-title":"Pembrolizumab in lung cancer: current evidence and future perspectives","volume":"15","author":"Palumbo G","year":"2019","unstructured":"Palumbo G, Carillio G, Manzo A, Montanino A. Pembrolizumab in lung cancer: current evidence and future perspectives. Future Oncol. 2019, 15:3327-3336. 10.2217\/fon-2019-0073","journal-title":"Future Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.05.002","article-title":"Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy","volume":"2","author":"Suozzi KC","year":"2016","unstructured":"Suozzi KC, Stahl M, Ko CJ, et al.. Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy. JAAD Case Rep. 2016, 2:264-268.  10.1016\/j.jdcr.2016.05.002","journal-title":"JAAD Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180572","article-title":"Pembrolizumab-induced sarcoid-like reactions during treatment of metastatic melanoma","volume":"289","author":"Cheshire SC","year":"2018","unstructured":"Cheshire SC,\u00a0Board RE,\u00a0Lewis AR,\u00a0Gudur LD, Dobson MJ. Pembrolizumab-induced sarcoid-like reactions during treatment of metastatic melanoma. Radiology. 2018, 289:564-567. 10.1148\/radiol.2018180572","journal-title":"Radiology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.75","article-title":"Immunopathogenesis of granulomas in chronic autoinflammatory disease","volume":"5","author":"Timmermans WM","year":"2016","unstructured":"Timmermans WM, van Laar JA, van Hagen PM, van Zelm MC. Immunopathogenesis of granulomas in chronic autoinflammatory disease. Clin Transl Immunol. 2016, 5:118. 10.1038\/cti.2016.75","journal-title":"Clin Transl Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","author":"Doty JD","unstructured":"Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest. 10.1378\/chest.127.3.1064","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4076\/1752-1947-3-8573","article-title":"Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report","volume":"3","author":"Patel SR","year":"2009","unstructured":"Patel SR. Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report. J Med Case Rep. 2009, 3:8573. 10.4076\/1752-1947-3-8573","journal-title":"J Med Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2010.00660.x","article-title":"Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis","volume":"52","author":"Marcella S","year":"2011","unstructured":"Marcella S, Welsh B, Foley P. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis. Australas J Dermatol. 2011, 52:8-11. 10.1111\/j.1440-0960.2010.00660.x","journal-title":"Australas J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.11.003","article-title":"Sarcoidosis appearing during anti-tumour necrosis factor-alpha therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review","volume":"39","author":"Massara A","year":"2010","unstructured":"Massara A, Cavazzini L, La Corte R, Trotta F. Sarcoidosis appearing during anti-tumour necrosis factor-alpha therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 2010, 39:313-319. 10.1016\/j.semarthrit.2008.11.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.02.015","article-title":"Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma","volume":"3","author":"Birnbaum MR","year":"2017","unstructured":"Birnbaum MR, Ma MW, Fleisig S, et al.. Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. JAAD Case Rep. 2017, 3:208-211. 10.1016\/j.jdcr.2017.02.015","journal-title":"JAAD Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2016-0037OC","article-title":"Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signalling impairs sarcoidosis CD4(+) T cell proliferation","volume":"56","author":"Celada LJ","year":"2017","unstructured":"Celada LJ, Rotsinger JE, Young A, et al.. Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signalling impairs sarcoidosis CD4(+) T cell proliferation. Am J Respir Cell Mol Biol. 2017, 56:74-82. 10.1165\/rcmb.2016-0037OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman RP","year":"2011","unstructured":"Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med. 2011, 183:573-581. 10.1164\/rccm.201006-0865CI","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers7020821","article-title":"Sarcoidosis in melanoma patients: case report and literature review","volume":"7","author":"Beutler BD","year":"2015","unstructured":"Beutler BD, Cohen PR. Sarcoidosis in melanoma patients: case report and literature review. Cancers (Basel). 2015, 7:1005-1021. 10.3390\/cancers7020821","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2016-0164","article-title":"Monitoring and management of immune-related adverse events associated with programmed cell death protein-1 axis inhibitors in lung cancer","volume":"22","author":"O'Kane GM","year":"2017","unstructured":"O'Kane GM, Labb\u00e9 C, Doherty MK, Young K, Albaba H, Leighl NB. Monitoring and management of immune-related adverse events associated with programmed cell death protein-1 axis inhibitors in lung cancer. Oncologist. 2017, 22:70-80.","journal-title":"Oncologist"},{"key":"ref15","article-title":"Sarcoidosis-like granulomatous reaction associated with pembrolizumab immunotherapy","author":"Garc\u00eda-Mansoa IG","year":"2018","unstructured":"Garc\u00eda-Mansoa IG, del Mar Garc\u00eda R\u00f3denasa M, Barroso Medela ME, Ill\u00e1n Gamb\u00ednb FJ. Sarcoidosis-like granulomatous reaction associated with pembrolizumab immunotherapy. Arch Bronconeumol. 2018,","journal-title":"Arch Bronconeumol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/48449-pembrolizumab-induced-sarcoid-like-reaction-in-a-patient-with-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:15Z","timestamp":1707506535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/48449-pembrolizumab-induced-sarcoid-like-reaction-in-a-patient-with-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.12395","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]}}}